hydralazine and thromboxane a2

hydralazine has been researched along with thromboxane a2 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bianchine, JR; Greenwald, JE; Panganamala, RV; Rao, M; Wong, LK1
Chan, CC; Ford-Hutchinson, A1
Jouppila, P; Kirkinen, P; Koivula, A; Ylikorkala, O1
Alexander, M; Bianchine, JR; Greenwald, JE; Wong, LK1
Fehér, J; Gachályi, B; Juhász, I; Székács, B1
Abe, Y; Chen, QH; Kosaka, H; Tian, RX; Yamamoto, A; Yoneyama, H; Zhang, L; Zhou, MS1
Arias, ME; Levy, JH; Sato, N; Szlam, F; Tanaka, KA; Tsuda, A1

Other Studies

7 other study(ies) available for hydralazine and thromboxane a2

ArticleYear
A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis.
    Biochemical and biophysical research communications, 1978, Oct-30, Volume: 84, Issue:4

    Topics: Arachidonic Acids; Blood Platelets; Diazoxide; Dipyridamole; Humans; Hydralazine; Kinetics; Male; Platelet Aggregation; Prostaglandins E; Prostaglandins F; Thromboxane A2; Thromboxanes

1978
Potentiation of the inhibitory effect of a thromboxane A2 antagonist (L-640,035) on arterial thrombosis formation in rabbit by the angiotensin converting enzyme inhibitor enalapril.
    European journal of pharmacology, 1985, Apr-16, Volume: 110, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Dibenzothiepins; Dipeptides; Drug Synergism; Enalapril; Female; Hexamethonium Compounds; Hydralazine; Male; Prostaglandin Antagonists; Rabbits; Radioimmunoassay; Thrombosis; Thromboxane A2; Thromboxanes

1985
Effects of dihydralazine infusion on the fetoplacental blood flow and maternal prostanoids.
    Obstetrics and gynecology, 1985, Volume: 65, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Blood Pressure; Dihydralazine; Female; Fetal Heart; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Placenta; Pre-Eclampsia; Pregnancy; Pulse; Regional Blood Flow; Thromboxane A2; Umbilical Veins

1985
In vivo inhibition of thromboxane biosynthesis by hydralazine.
    Advances in prostaglandin and thromboxane research, 1980, Volume: 6

    Topics: Animals; Aorta; Arachidonic Acids; Blood Platelets; Hydralazine; Kinetics; Male; Muscle, Smooth, Vascular; Rabbits; Thromboxane A2; Thromboxanes

1980
TxA2-PGI2-PGF2 alfa responses in the kidney to blood pressure reduction induced by vasodilator/vasorelaxing agents with different action in patients with essential hypertension.
    Acta physiologica Hungarica, 1993, Volume: 81, Issue:4

    Topics: Adolescent; Adult; Blood Pressure; Dinoprost; Epoprostenol; Female; Gallopamil; Glomerular Filtration Rate; Humans; Hydralazine; Hypertension; Kidney; Male; Middle Aged; Prazosin; Prostaglandins; Sodium; Thromboxane A2; Vasodilator Agents; Venous Pressure

1993
L-Arginine improves endothelial function in renal artery of hypertensive Dahl rats.
    Journal of hypertension, 2001, Volume: 19, Issue:3

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Arginine; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cyclic GMP; Endothelins; Endothelium, Vascular; Fatty Acids, Unsaturated; Hydralazine; Hydrazines; Hypertension; In Vitro Techniques; Indomethacin; Male; Methacrylates; Natriuresis; Nitrates; Nitrites; Nitroprusside; Rats; Rats, Inbred Dahl; Renal Artery; Thromboxane A2; Vasoconstriction

2001
The vasodilatory effects of hydralazine, nicardipine, nitroglycerin, and fenoldopam in the human umbilical artery.
    Anesthesia and analgesia, 2003, Volume: 96, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Dopamine; Dose-Response Relationship, Drug; Female; Fenoldopam; Humans; Hydralazine; In Vitro Techniques; Muscle Contraction; Nicardipine; Nitroglycerin; Potassium Chloride; Pre-Eclampsia; Pregnancy; Receptors, Adrenergic, alpha; Thromboxane A2; Umbilical Arteries; Vasoconstrictor Agents; Vasodilator Agents

2003